secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001437749-25-025935
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision Q2 revenue up 128% YoY to $212K; net loss $5.4M with $3.2M non-cash
--------------------------------------------------------------------------------

- Revenue $212K for Q2 2025 vs $93K in Q2 2024, 128% increase; sequential growth 48%.
- Net loss $5.4M for Q2 includes $3.2M non-cash charges; cash $838K at June 30.
- Received CE Mark for LockeT product; European sales expected to start in Q3 2025.
- Completed acquisition of Cardionomic heart failure assets via 82%-owned subsidiary Cardionomix.
- Formed Kardionav JV for implant-based software to locate ventricular tachycardia ablation sites.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925025935/0001437749-25-025935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925025935/vtak20250811_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-025935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer